Premorbid brain volume estimates and reduced total brain volume in adults exposed to trauma with or without posttraumatic stress disorder: a meta-analysis.

OBJECTIVE: The primary objective of this study was to meta-analytically investigate whether total brain volume (TBV) and total intracranial volume (TICV) differ between adult participants with posttraumatic stress disorder (PTSD) and controls. BACKGROUND: TICV reaches maximum growth by early adolescence and provides an estimate of premorbid brain size. Little work has directly examined TBV in PTSD participants, although limited evidence suggests that deficits in brain volume may occur. METHODS: Using electronic databases, we identified articles containing TBV and TICV data for adult PTSD participants. Data were extracted and effect sizes were calculated. RESULTS: We identified 8 studies with TBV data (105 PTSD participants and 122 trauma-unexposed controls) and 2 studies with TICV data (18 PTSD participants and 25 trauma-unexposed controls). TBV was significantly smaller in PTSD participants compared with trauma-unexposed controls. In contrast, TICV did not differ between these groups. There were no significant differences in TBV and TICV between PTSD and trauma-exposed controls. CONCLUSIONS: TBV is significantly smaller in adult PTSD participants compared with trauma-unexposed controls. TICV did not differ significantly between these groups, suggesting that a deficit in TBV occurred at some point after the attainment of maximum brain volume in the PTSD group.

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.

Obsessive-compulsive disorder (OCD) is a common and severe neuropsychiatric disorder treated by both behavioral and pharmacologic techniques. Despite the availability of treatments for OCD, including the selective serotonin reuptake inhibitors (SSRIs), many OCD patients have an inadequate response to current treatments. As such, additional approaches to the management of OCD are required. A potential but little studied treatment for OCD is the SSRI escitalopram. Escitalopram is the S-enantiomer of citalopram, the preparation containing both S and R enantiomers of citalopram. Not only is escitalopram the most selective of the SSRIs, it is also devoid of R-citalopram, which may interfere with the effects of the S enantiomer. Escitalopram appears to be effective in depression and several anxiety disorders, including social anxiety disorder and generalized anxiety disorder, conditions in which it also appears reasonably well tolerated. Enantiomeric specificity, high serotonin reuptake selectivity, comparatively good tolerability and favorable pharmacokinetics, and preliminary evidence of efficacy in OCD suggest a potential role for the use of escitalopram in the treatment of OCD. Nevertheless, additional work including evaluating the use of escitalopram with behavioral interventions and in long-term treatment of OCD is needed to clarify its overall role in managing OCD.

Neuroimaging, cognitive, and neurobehavioral outcomes following carbon monoxide poisoning.

Carbon monoxide is a colorless, odorless gas produced as a byproduct of combustion. Carbon monoxide is the leading cause of poisoning injury and death worldwide. Morbidity following CO poisoning includes neurologic sequelae, neuropathologic abnormalities on brain imaging, neurobehavioral changes, and cognitive impairments. It is estimated that as high as 50% of individuals with carbon monoxide poisoning will develop neurologic, neurobehavioral, or cognitive sequelae. Carbon monoxide related cognitive impairments included impaired memory, attention, executive function, motor, visual spatial, and slow mental processing speed. Given the high rate of brain related morbidity and the fact that the majority of carbon monoxide is avoidable, awareness and prevention of carbon monoxide poisoning is warranted.